ResearcherCornell UniversityActive in the last 2 years
Jedd D. Wolchok
Matched on ORCID iD 0000-0001-6718-2222; OpenAlex author ID A5054656505. Sources: OpenAlex.
Their work
- Papers
- 6 (first author 0, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 43
2014: 1 paper · 2015: none · 2016: none · 2017: 1 paper · 2018: 1 paper · 2019: none · 2020: none · 2021: none · 2022: 1 paper · 2023: 1 paper · 2024: none · 2025: 1 paper
Papers 6
- RNA neoantigen vaccines prime long-lived CD8+ T cells in pancreatic cancer. Co-author DOI 10.1038/s41586-024-08508-4↗
- Personalized RNA neoantigen vaccines stimulate T cells in pancreatic cancer. Co-author DOI 10.1038/s41586-023-06063-y↗
- Neoantigen quality predicts immunoediting in survivors of pancreatic cancer. Co-author DOI 10.1038/s41586-022-04735-9↗
- Acquired resistance to immunotherapy in MMR-D pancreatic cancer. Co-author DOI 10.1186/s40425-018-0448-1↗
- Identification of unique neoantigen qualities in long-term survivors of pancreatic cancer. Co-author DOI 10.1038/nature24462↗
- Depression, cytokines, and pancreatic cancer. Last author DOI 10.1002/pon.3422↗
Closest collaborators
The 25 strongest of 43 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Benjamin D. Greenbaum · 3 shared papers, 2017–2025 · strength 0.30
- Paper RNA neoantigen vaccines prime long-lived CD8+ T cells in pancreatic cancer. DOI 10.1038/s41586-024-08508-4↗
- Paper Neoantigen quality predicts immunoediting in survivors of pancreatic cancer. DOI 10.1038/s41586-022-04735-9↗
- Paper Identification of unique neoantigen qualities in long-term survivors of pancreatic cancer. DOI 10.1038/nature24462↗
- Vinod P. Balachandran · 3 shared papers, 2017–2025 · strength 0.30
- Paper RNA neoantigen vaccines prime long-lived CD8+ T cells in pancreatic cancer. DOI 10.1038/s41586-024-08508-4↗
- Paper Neoantigen quality predicts immunoediting in survivors of pancreatic cancer. DOI 10.1038/s41586-022-04735-9↗
- Paper Identification of unique neoantigen qualities in long-term survivors of pancreatic cancer. DOI 10.1038/nature24462↗
- Taha Merghoub Merghoub · 3 shared papers, 2017–2025 · strength 0.30
- Paper RNA neoantigen vaccines prime long-lived CD8+ T cells in pancreatic cancer. DOI 10.1038/s41586-024-08508-4↗
- Paper Neoantigen quality predicts immunoediting in survivors of pancreatic cancer. DOI 10.1038/s41586-022-04735-9↗
- Paper Identification of unique neoantigen qualities in long-term survivors of pancreatic cancer. DOI 10.1038/nature24462↗
- Zachary M. Sethna · 2 shared papers, 2022–2025 · strength 0.25
- Luis Alfonso Rojas · 2 shared papers, 2022–2025 · strength 0.25
- Kevin C. Soares · 2 shared papers, 2022–2025 · strength 0.25
- Masataka Amisaki · 2 shared papers, 2022–2025 · strength 0.25
- Eileen Mary O'Reilly · 2 shared papers, 2018–2025 · strength 0.24
- Olca Baştürk · 2 shared papers, 2017–2025 · strength 0.20
- Ryan Sugarman · 1 shared paper, 2025 · strength 0.15
- Anna M. Varghese · 1 shared paper, 2025 · strength 0.15
- Özlem Türeci · 1 shared paper, 2025 · strength 0.15
- T. Peter Kingham · 1 shared paper, 2025 · strength 0.15
- Akihiro Ohmoto · 1 shared paper, 2025 · strength 0.15
- Michael Ian D'Angelica · 1 shared paper, 2025 · strength 0.15
- Ira Mellman · 1 shared paper, 2025 · strength 0.15
- Wungki Park · 1 shared paper, 2025 · strength 0.15
- Uğur Şahin · 1 shared paper, 2025 · strength 0.15
- Andrew S. Epstein · 1 shared paper, 2025 · strength 0.15
- Jeffrey A. Drebin · 1 shared paper, 2025 · strength 0.15
- Elizabeth S. Won · 1 shared paper, 2025 · strength 0.15
- William R. Jarnagin · 1 shared paper, 2025 · strength 0.15
- Alice Chia-Chi Wei · 1 shared paper, 2025 · strength 0.15
- Marta Łuksza · 2 shared papers, 2017–2022 · strength 0.15
- Christine A. Iacobuzio–Donahue · 2 shared papers, 2017–2022 · strength 0.15
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.